SATISH C SINGLA

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology POTTSVILLE, PA NPI 1730186396

General Payments — all program years on this page

$5,690.21

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 198
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $577.65 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $492.6519
Education $85.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $651.1329
2019 $781.5922
2020 $425.2316
2021 $1,145.1031
2022 $921.1337
2023 $1,188.3843
2024 $577.6520

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086181377 Bayer Healthcare Pharmaceuticals Inc. $73.07 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087258271 Novartis Pharmaceuticals Corporation $13.29 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087258273 Novartis Pharmaceuticals Corporation $20.31 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087258277 Novartis Pharmaceuticals Corporation $15.84 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087258279 Novartis Pharmaceuticals Corporation $15.41 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087258281 Novartis Pharmaceuticals Corporation $16.07 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089483901 Daiichi Sankyo Inc. $25.57 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105749521 AstraZeneca Pharmaceuticals LP $17.20 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110780166 Eisai Inc. $122.85 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131308864 PFIZER INC. $19.99 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131325640 PFIZER INC. $21.47 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131348585 PFIZER INC. $14.15 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131364186 PFIZER INC. $16.00 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131366046 PFIZER INC. $17.85 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131586051 ARRAY BIOPHARMA INC $16.96 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141424765 SOBI, INC $85.00 04/15/2024 Education Undisputed 01/23/2026 View at CMS
1141643054 Merck Sharp & Dohme LLC $16.81 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141643056 Merck Sharp & Dohme LLC $13.77 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141643058 Merck Sharp & Dohme LLC $16.76 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150174738 Tempus AI, Inc $19.28 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.